SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

Larimar Therapeutics Q1 EPS $(0.76) Up From $(1.10) YoY

Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.76) per share. This is a 30.91 percent increase over losses of $(1.10) per share from the same period last year.

05/10/2021 16:43
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.76) per share. This is a 30.91 percent increase over losses of $(1.10) per share from the same period last year.